Thymoma-a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose.
about
Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institutionAdjuvant Radiotherapy for Stages II and III Resected Thymoma: A Single-institutional Experience.Thymic epithelial tumors in a worldwide perspective: lessons from observational studies.Survival and treatments in patients with incompletely resected thymoma.
P2860
Thymoma-a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Thymoma-a clinico-pathological ...... nd adjuvant radiotherapy dose.
@en
type
label
Thymoma-a clinico-pathological ...... nd adjuvant radiotherapy dose.
@en
prefLabel
Thymoma-a clinico-pathological ...... nd adjuvant radiotherapy dose.
@en
P2093
P1476
Thymoma-a clinico-pathological ...... nd adjuvant radiotherapy dose.
@en
P2093
Alexander Marx
Edwin Bölke
Philipp Ströbel
Reinhart Willers
Stephan Gripp
Thomas Harnath
P304
P356
10.1097/JTO.0B013E3182745F73
P577
2012-12-01T00:00:00Z